Implications uptake meta-iodobenzylguanidine mIBG targeted radiotherapy neuroblastoma Selective uptake meta-iodobenzylguanidine mIBG neuroblastoma possible approach targeted radiotherapy disease mathematical model absorbed doses tumours size therapeutic measurements uptake tumours patients size categories tumour target bulk tumour microscopic disease predicted absorbed doses doses probability tumour cure analysis probability tumour cure mIBG uptake effective half-life mIBG tumour tumour diameter Small microtumours resistant treatment limited absorption beta-energy product patient mass percentage unit mass tumour useful indicator therapeutic outcome radiotherapy treatment paediatric tumours 